Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_assertion type Assertion NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_head.
- NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_provenance.
- NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_assertion evidence source_evidence_literature NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_provenance.
- NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_assertion SIO_000772 21289241 NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_provenance.
- NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_assertion wasDerivedFrom befree-20140225 NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_provenance.
- NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_assertion wasGeneratedBy ECO_0000203 NP634942.RAGjStnVZC4a4Eqz5O555ge3DP-rHNoUvYUIHAFNOg08E130_provenance.